Skip to main content

Advertisement

Fig. 7 | BMC Complementary and Alternative Medicine

Fig. 7

From: A yeast fermentate improves gastrointestinal discomfort and constipation by modulation of the gut microbiome: results from a randomized double-blind placebo-controlled pilot trial

Fig. 7

Principal component analysis (47.4%) of the relative fold-changes calculated for all taxonomic groups (family and genus levels). Each dot represents a treated group (either EpiCor or placebo) for all three cohorts (total cohort, severe and moderate). The first component (PC1) accounts for nearly 28% of the variance, and the second component (PC2) for nearly 20%. legend: E, Epicor; P, placebo; V, visit

Back to article page